Tositumomab (Bexxar)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tositumomab (Bexxar), covering 2017-01-27 to 2017-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]